ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02869633
Brief Title: Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

First Submitted : August 10, 2016
First Submitted that Met QC Criteria : August 12, 2016
First Posted : August 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 20, 2018
Last Update Posted : August 21, 2018